Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.

Human molecular genetics - 1 Apr 2001

Wade P A

Abstract excerpt

Cancer cells exhibit a set of unique properties that distinguish them from their normal counterparts. Among these features are increased growth rates, loss of differentiation, escape from cell death pathways, evasion of anti-proliferative signals, a decreased reliance on exogenous growth factors...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Nucleus
Share to Chromatin
Share to Cytoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Damage

Share to Histone Deacetylase 1

Share to Histone Deacetylases

Share to Histones

Share to Retinoblastoma Protein

Source

Identifiers

PMID: 11257101
DOI: 10.1093/hmg/10.7.693

Genes

HDAC1
HDAC2
HDAC4
HDAC5
HDAC6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11257101-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin.PMID 11257101Read ↗

Histone-Deacetylase Inhibitors for the Treatment of CancerSemantic proximity Read ↗

Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagySemantic proximity Read ↗

Histone deacetylases as therapeutic targets in hematologic malignanciesSemantic proximity Read ↗

Apoptotic pathways activated by histone deacetylase inhibitors: implications for the drug-resistant phenotype.Semantic proximity Read ↗

Cell cycle checkpoint signaling involved in histone deacetylase inhibition and radiation-induced cell deathSemantic proximity Read ↗

Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted TherapySemantic proximity Read ↗

How do tumor cells respond to HDAC inhibition?Semantic proximity Read ↗

Histone Deacetylation of RB-Responsive Promoters: Requisite for Specific Gene Repression but Dispensable for Cell Cycle InhibitionSemantic proximity Read ↗

Therapeutic Strategies for RB1-Deficient Cancers: Intersecting Gene Regulation and Targeted TherapySemantic proximity Read ↗

Mechanisms of HDACs in cancer developmentSemantic proximity Read ↗

Role of HDACs in normal and malignant hematopoiesisSemantic proximity Read ↗

Histone Deacetylase Inhibitors in Cancer TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.